Editors' Pick Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis. Rahn KA, Watkins CC, Alt J, Rais R, Stathis M, Grishkan I, Crainiceau CM, Pomper MG, Rojas C, Pletnikov MV, et al. Proc Natl Acad Sci U S A. 2012 Dec 4; 109(49):20101-6. Epub 2012 Nov 19. PMID: 23169655. Abstract CommentRecommendBookmarkWatch